Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
100 participants
OBSERVATIONAL
2024-11-19
2025-06-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
We hypothesise that exhalations through the device is uncommon and that the interface resistance restricts flow from the patient. If expiratory flows are uncommon the RAM interface provide support clinically comparable to other systems based on unidirectional flow such as humidified high-flow cannula.
This is a cross-sectional, observational study (no intervention) in newborn infants that are clinically stable and on respiratory support with the RAM interface connected to a bCPAP circuit. This is the most common support in the Phu San neonatal unit. The time needed for data collection is short and collection is expected to take approximately five minutes (less than 15 minutes) in a quiet infant. The collection can be planned to minimize disturbances for the infant, parents and staff. For example, the busiest times of the day can be avoided to not intervene with daily care, ward rounds or examinations of the infant.
Data on flow and pressure will be collected within the respiratory support circuit at the connection to the RAM interface. The measurements are passive, and no tests or manipulation of the infant is planned. There will be brief interruptions (\<1 min) in respiratory support when the meters are connected. Similar interruptions are very common and occurs several times per day during normal care.
Data will be collected in case report forms (CRF) with REDCap electronic data capture tool. All personal identifiers will be removed before data export from REDCap and further analysis only using enrolment numbers.
Background variables describing the pregnancy, delivery and the infant will be collected. We also will record details of the RAM-cannula interface, such as size, protective dressing, gastric feeding tube, obvious leak at nares and mouth.
During the measurement the infant will be monitored for vital signs and any problems will be addressed and recorded. This includes oxygen need, CPAP support and breathing problems. The flow and pressure data for one minute of quiet breathing will be stored locally with the enrolment number as identifier. The analysis after collection of flow and pressure will include average flow in the CPAP circuit, the flow to the patient, average absolute leak and delivered pressure. If a variation with breathing can be seen this will be described. These output variables directly relate to the research questions.
1. What flows and pressure can be observed in the breathing circuit? \[Measured average flows, pressure and variability between patients\]
2. Do infants exhale through the RAM interface? \[Measured expiratory flows at the interface\]
3. What is the level of leak for the interface? \[Measured absolute leak\]
The RAM cannula interface has been widely introduced but is not CE-marked for CPAP support. It has an advantage of being more comfortable and light weight with less nasal injury in most trials. The high resistance of the RAM interface has been discussed as problematic by several authors, but the clinical importance is not known. Comparing RAM interface to other CPAP interfaces in clinical trials is difficult and, if RAM has a treatment effect similar to HHFNC, very large trials of high quality would be needed.
The described study will generate new knowledge on the RAM interface by describing patient flow through the interface and illustrate the importance of resistance and leak. The study is not strictly a physiological study but investigate flow in an airway interface. The most likely outcome is that exhalation is uncommon, and this would support that the RAM interface has more similarities with HHFNC than conventional CPAP.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Diaphragm Electrical Activity of Preterm Infants on nCPAP With Binasal Prongs Versus RAM Cannula
NCT03121781
Neotech RAM Cannula Versus Conventional Binasal Prong Continuous Positive Airway Pressure (CPAP) to Treat Respiratory Distress in Low Birth Weight Neonates
NCT02168257
FiO2 Delivered With Neonatal bCPAP
NCT06615427
Crossover Comparison of Tidal Volume Delivery During Nasal Intermittent Positive Pressure Ventilation in Preterm Infants: Infant Cannula vs. Nasal Continuous Positive Airway Pressure Prongs
NCT04326270
Airway Pressure During Nasal High Flow and CPAP in Neonates
NCT02632799
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
OTHER
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Infant treated with bubble CPAP and receiving blended air/oxygen
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Support with bubble CPAP and RAM interface
* Quiet and stable spontaneous breathing
* Investigation team available
Exclusion Criteria
* Major congenital malformation
* Known syndrome or neuromuscular disease
* Circulatory instability with inotropes
* Oxygen need \>50% or CPAP \>10 cm H2O
* Surfactant given the last 6 hours or expected to be needed the next 6 hours
* Expected to need NIPPV or intubation within 6 hours
* Recently extubated (\<24 h)
* Recent large surgical procedure (\<5 days)
* Nasal wound or irritation that hurts or is at risk of worsening during study
0 Hours
3 Months
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Karolinska Institutet
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Thomas Drevhammar
Ass. Prof. (Docent)
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Phu San Hanoi Hospital
Hanoi, Hanoi, Vietnam
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1758 CN/PS
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.